HOXHA, MALVINA
HOXHA, MALVINA
Dipartimento di Scienze Farmacologiche e Biomolecolari
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile
2014 M. Hoxha, V. Capra, C. Buccellati, A. Sala, C. Cena, R. Fruttero, M. Bertinaria, G.E. Rovati
A potential role of PUFAs and COXIBs in cancer chemoprevention
2015 M. Vara Messler, C. Buccellati, L. Pustina, G. Folco, G..E. Rovati, M. Hoxha
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors
2012 M. Bertinaria, M.A.A.G Shaikh, C. Buccellati, C. Cena, B. Rolando, L Lazzarato, R. Fruttero, A. Gasco, M. Hoxha, V. Capra, A. Sala, G.E. Rovati
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition
2016 M. Hoxha, C. Buccellati, V. Capra, D. Garella, C. Cena, B. Rolando, R. Fruttero, S. Carnevali, A. Sala, G.E. Rovati, M. Bertinaria
Montelukast Use Decreases Cardiovascular Events in Asthmatics
2021 M. Hoxha, C.C. Tedesco, S. Quaglin, V. Malaj, L. Pustina, V. Capra, J.F. Evans, A. Sala, G. Rovati
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field
2017 M. Hoxha, G..E. Rovati, A.B. Cavanillas
THE POTENTIAL THERAPEUTIC ROLE OF MONTELUKAST AND NEW HYBRID AGENTS, TXA2 ANTAGONIST-COX-2 INHIBITORS IN CARDIOVASCULAR EVENTS
2016 M. Hoxha